Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC
Clinical trial NCT01917279 · UNKNOWN
Trial details
- NCT number
- NCT01917279
- Sponsor
- Binghe Xu
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2020-07-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.